SCHEMBL5311576

SCHEMBL5311576

O=c1[nH]c(F)cc2ccccc12

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.60
GAA P10253 3/20 0.60
LOXL2 Q9Y4K0 1/20 0.56
CDC25B P30305 10/20 0.54
APAF1 O14727 6/20 0.54
ALDH1A1 P00352 5/20 0.54
CASP3 P42574 5/20 0.54
SENP8 Q96LD8 5/20 0.54
SENP7 Q9BQF6 5/20 0.54
HPGD P15428 4/20 0.54
SENP6 Q9GZR1 4/20 0.54
SAE1 Q9UBE0 4/20 0.54
UBA2 Q9UBT2 4/20 0.54
THRB P10828 4/20 0.54
CASP6 P55212 4/20 0.54
MAPT P10636 3/20 0.54
TDP2 O95551 3/20 0.54
RECQL P46063 2/20 0.54
CASP7 P55210 2/20 0.54
CASP9 P55211 2/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29784203 0.75 KDM4E (0.60) KDM4EGAALOXL2CDC25BAPAF1
SCHEMBL6448568 0.75 KDM4E (0.60) KDM4EGAALOXL2CDC25BAPAF1
SCHEMBL29844316 0.75 LOXL2 (0.61) KDM4EGAALOXL2CDC25BAPAF1
SCHEMBL1687342 0.75 KDM4E (0.60) KDM4EGAALOXL2CDC25BAPAF1
SCHEMBL1818129 0.75 KDM4E (0.60) KDM4EGAALOXL2CDC25BAPAF1
SCHEMBL824574 0.75 KDM4E (1.00) KDM4EGAALOXL2CDC25BAPAF1
SCHEMBL150458 0.75 KDM4E (0.60) KDM4EGAALOXL2CDC25BAPAF1
SCHEMBL29488099 0.75 KDM4E (1.00) KDM4EGAALOXL2CDC25BAPAF1
SCHEMBL1719778 0.75 LOXL2 (0.61) KDM4EGAALOXL2CDC25BAPAF1
SCHEMBL25911541 0.75 KDM4E (0.60) KDM4EGAALOXL2CDC25BAPAF1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116574056-A Preparation method of fluoroisoquinolone compound 五邑大学 2023-08-11 CN claimed
CN-116574056-A Preparation method of fluoroisoquinolone compound 五邑大学 2023-08-11 CN disclosed
CN-116574056-A Preparation method of fluoroisoquinolone compound 五邑大学 2023-08-11 CN disclosed
CN-116574056-A Preparation method of fluoroisoquinolone compound 五邑大学 2023-08-11 CN disclosed
CN-108368053-A Substituted benzazepine derivatives as antibacterial compounds 葛兰素史密斯克莱知识产权发展有限公司 2018-08-03 CN disclosed
CN-105859617-A Fluoroisoquinolone compound and synthesis method thereof 叶芳 2016-08-17 CN disclosed
CN-105859617-A Fluoroisoquinolone compound and synthesis method thereof 叶芳 2016-08-17 CN disclosed
WO-2007053352-A2 PYRROLOQUINOLINONE DERIVATIVES AS 5-HYDROXYTRYPTAMINE-6 LIGANDS WYETH (US) 2007-05-10 WO disclosed
US-20070099911-A1 Pyrroloquinolinone derivatives as 5-hydroxytryptamine-6 ligands WYETH (US) 2007-05-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070099911-A1 Pyrroloquinolinone derivatives as 5-hydroxytryptamine-6 ligands HTR6, HTR5A, HTR2C KDM4E 3529/4885GAA 3571/4885LOXL2 2442/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.